相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Acute toxicity is a dose-limiting factor for intravenous polymyxin B: A safety and pharmacokinetic study in healthy Chinese subjects
Xiaofen Liu et al.
JOURNAL OF INFECTION (2021)
Hematocrit, blood volume, and surface area of dried blood spots - a quantitative model
Mervat M. Alsous et al.
DRUG TESTING AND ANALYSIS (2020)
Vancomycin and creatinine determination in dried blood spots: Analytical validation and clinical assessment
Leticia Scribel et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2020)
Development of a dried blood spot sampling method towards therapeutic monitoring of radotinib in the treatment of chronic myeloid leukaemia
Jihyun Lee et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2020)
Dried plasma spots for therapeutic monitoring of amikacin: Validation of an UHPLC-MS/MS assay and pharmacokinetic application
Anne Caroline Cezimbra da Silva et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2020)
International Consensus Guidelines for the Optimal Use of the Polymyxins Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)
Brian T. Tsuji et al.
PHARMACOTHERAPY (2019)
The re-emergence of dried blood spot sampling - are we ready?
Rosita Zakaria et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)
Analysis of the Heterogeneous Distribution of Amiloride and Propranolol in Dried Blood Spot by UHPLC-FLD and MALDI-IMS
Beatriz Uribe et al.
MOLECULES (2019)
Antimicrobial Susceptibility Testing for Polymyxins: Challenges, Issues, and Recommendations
Fereshteh Ezadi et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2019)
Is the hematocrit still an issue in quantitative dried blood spot analysis?
Sofie Velghe et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2019)
The development and validation of a simple liquid chromatography-tandem mass spectrometry method for polymyxin B1 and B2 quantification in different matrices
Jenna Covelli et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2017)
An on-spot internal standard addition approach for accurately determining colistin A and colistin B in dried blood spots using ultra high-performance liquid chromatography-tandem mass spectrometry
I-Lin Tsai et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2017)
Development of a dried blood spot HPLC-PDA method for the analysis of linezolid and ciprofloxacin in hospital-acquired pneumonia patients
Vincenzo Ferrone et al.
DRUG TESTING AND ANALYSIS (2017)
Validation and Application of a Dried Blood Spot Ceftriaxone Assay
Madhu Page-Sharp et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Simultaneous quantitation of polymyxin B1, polymyxin B2 and polymyxin B1-1 in human plasma and treated human urine using solid phase extraction and liquid chromatography-tandem mass spectrometry
Min Meng et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2016)
Development and validation of UHPLC-MS/MS methods for the quantification of colistin in plasma and dried plasma spots
Giuliana Cangemi et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2016)
Clinical feasibility of dried blood spots: Analytics, validation, and applications
Yeliz Enderle et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2016)
Polymyxin B versus colistin: an update
Yiying Cai et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2015)
Antimicrobial Activity and Toxicity of the Major Lipopeptide Components of Polymyxin B and Colistin: Last-Line Antibiotics against Multidrug-Resistant Gram-Negative Bacteria
Kade D. Roberts et al.
ACS INFECTIOUS DISEASES (2015)
Colistin and Polymyxin B: Peas in a Pod, or Chalk and Cheese?
Roger L. Nation et al.
CLINICAL INFECTIOUS DISEASES (2014)
Procedures and practices for the validation of bioanalytical methods using dried blood spots: a review
Nynke G. L. Jager et al.
BIOANALYSIS (2014)
Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens
Ana M. Sandri et al.
CLINICAL INFECTIOUS DISEASES (2013)
A validated ultra-performance liquid chromatography-tandem mass spectrometry method for the quantification of polymyxin B in mouse serum and epithelial lining fluid: application to pharmacokinetic studies
Jie He et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Merck's perspective on the implementation of dried blood spot technology in clinical drug development - why, when and how
Yang Xu et al.
BIOANALYSIS (2013)
Hemato-critical issues in quantitative analysis of dried blood spots: challenges and solutions
Pieter M. M. De Kesel et al.
BIOANALYSIS (2013)
Direct analysis of dried blood spots coupled with mass spectrometry: concepts and biomedical applications
Julien Deglon et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2012)
Simultaneous measurement of cyclosporin A and tacrolimus from dried blood spots by ultra high performance liquid chromatography tandem mass spectrometry
Edward Hinchliffe et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2012)
Development of an UPLC-MS/MS method for the determination of antibiotic ertapenem on dried blood spots
Giancarlo la Marca et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2012)
What is next for dried blood spots?
Qin C. Ji et al.
BIOANALYSIS (2012)
The analysis of dried blood spot samples using liquid chromatography tandem mass spectrometry
Brian G. Keevil
CLINICAL BIOCHEMISTRY (2011)
Determination of moxifloxacin in dried blood spots using LC-MS/MS and the impact of the hematocrit and blood volume
D. H. Vu et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2011)
EBF recommendation on the validation of bioanalytical methods for dried blood spots
Philip Timmerman et al.
BIOANALYSIS (2011)
Use of Dried Blood Spots in Drug Development: Pharmacokinetic Considerations
Malcolm Rowland et al.
AAPS JOURNAL (2010)
Impact of various factors on radioactivity distribution in different DBS papers
Xiao Ren et al.
BIOANALYSIS (2010)
Pharmacokinetic considerations as to when to use dried blood spot sampling
Gary Emmons et al.
BIOANALYSIS (2010)
Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients
Alexandre P. Zavascki et al.
CLINICAL INFECTIOUS DISEASES (2008)
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
Matthew E. Falagas et al.
CRITICAL CARE (2006)
分享论文
